Longeveron, Inc. (LGVN)
0.9505
-0.01
(-0.99%)
USD |
NASDAQ |
Mar 18, 13:32
Longeveron EPS Diluted (Quarterly) : -0.393 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Acadia Healthcare Co., Inc. | -13.02 |
| Charles River Laboratories International, Inc. | -5.619 |
| BioRestorative Therapies, Inc. | -0.3333 |
| HeartBeam, Inc. | -0.1462 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.221M |
| Revenue (Quarterly) | 0.137M |
| Total Expenses (Quarterly) | 7.358M |
| Enterprise Value | 12.22M |
| Gross Profit Margin (Quarterly) | -102.2% |
| Profit Margin (Quarterly) | -5.27K% |
| Earnings Yield | -140.7% |
| Normalized Earnings Yield | -140.67 |